Skip to main content
Top
Published in: BMC Infectious Diseases 1/2017

Open Access 01-12-2017 | Research article

Decline in hospitalization for genital warts in the Veneto region after an HPV vaccination program: an observational study

Authors: Silvia Cocchio, Tatjana Baldovin, Chiara Bertoncello, Alessandra Buja, Patrizia Furlan, Mario Saia, Vincenzo Baldo

Published in: BMC Infectious Diseases | Issue 1/2017

Login to get access

Abstract

Background

Human papillomavirus (HPV) is one of the most common sexually transmitted pathogens. This observational study was conducted to estimate the trend of hospitalization for genital warts (GWs) in the Veneto region (Italy) from 2004 to 2015.

Methods

All patients with GWs were identified in the hospital discharge records of all public and accredited private hospitals that related to Veneto residents and contained the ICD9-CM code 078.11 associated with a genital surgical procedure (vulval/vaginal warts, penile warts and anal warts). Annual total and sex- and age-specific hospitalization rates and trends were calculated and correlated with the different HPV vaccine coverage over the study period.

Results

An annual rate of 11.8 per 100,000 population (8.6 per 100,000 males, and 14.8 per 100,000 females) was found, corresponding to 6076 hospitalizations for condyloma (53.3% vulval/vaginal, 35.8% anal, 8.3% penile, and 2.6% both penile or vulval/vaginal and anal). Among females, the rate of overall GWs remained stable to 2007 (19.1 per 100,000), then dropped significantly, reaching a rate of 11.3 per 100,000 in 2015 (average annual percent changes [AAPC]: -6.1%; 95% CI: -8.4; −3.7). For males, the overall rate increased over the study period (from 6.4 per 100,000 in 2004 to 10.8 per 100,000 in 2015; AAPC: 3.8%; 95% CI: 1.2; 6.4).
Among the potentially vaccinated females (12- to 20-year-olds) there was a 62.1% decrease in the number of vulval/vaginal warts from the years 2010-2012 to the years 2013-2015 due to an increase in the HPV coverage rate. A similar reduction among males was observed in the same period and the same age group for penile warts (−68.2%).

Conclusion

GWs have an important impact on the health services and data suggest that GW-related hospitalization rates rapidly decline in a population with a high HPV vaccination coverage (about 75%). Further efforts should be made to better clarify the epidemiological picture regarding HPV-related diseases, with particular regard to sexual behavior.
Literature
1.
go back to reference Garland SM, Steben M, Sings HL, et al. Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine. J Infect Dis. 2009;199(6):805–14.CrossRefPubMed Garland SM, Steben M, Sings HL, et al. Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine. J Infect Dis. 2009;199(6):805–14.CrossRefPubMed
2.
go back to reference Kraut AA, Schink T, Schulze-Rath R, Mikolajczyk RT, Garbe E. Incidence of anogenital warts in Germany: a population-based cohort study. BMC Infect Dis. 2010;10:360.CrossRefPubMedPubMedCentral Kraut AA, Schink T, Schulze-Rath R, Mikolajczyk RT, Garbe E. Incidence of anogenital warts in Germany: a population-based cohort study. BMC Infect Dis. 2010;10:360.CrossRefPubMedPubMedCentral
6.
go back to reference Boehmer TK, Patnaik JL, Burnite SJ, Ghosh TS, Gershman K, Vogt RL. Use of hospital discharge data to evaluate notifiable disease reporting to Colorado's electronic disease reporting system. Public Health Rep. 2011;126:100–6.CrossRefPubMedPubMedCentral Boehmer TK, Patnaik JL, Burnite SJ, Ghosh TS, Gershman K, Vogt RL. Use of hospital discharge data to evaluate notifiable disease reporting to Colorado's electronic disease reporting system. Public Health Rep. 2011;126:100–6.CrossRefPubMedPubMedCentral
7.
go back to reference Marra F, Ogilvie G, Colley L, Kliewer E, Marra CA. Epidemiology and costs associated with genital warts in Canada. Sex Transm Infect. 2009;85(2):111–5.CrossRefPubMed Marra F, Ogilvie G, Colley L, Kliewer E, Marra CA. Epidemiology and costs associated with genital warts in Canada. Sex Transm Infect. 2009;85(2):111–5.CrossRefPubMed
8.
go back to reference Hillemanns P, Breugelmans JG, Gieseking F, Bénard S, Lamure E, Littlewood KJ, Petry KU. Estimation of the incidence of genital warts and the cost of illness in Germany: a cross-sectional study. BMC Infect Dis. 2008;8:76.CrossRefPubMedPubMedCentral Hillemanns P, Breugelmans JG, Gieseking F, Bénard S, Lamure E, Littlewood KJ, Petry KU. Estimation of the incidence of genital warts and the cost of illness in Germany: a cross-sectional study. BMC Infect Dis. 2008;8:76.CrossRefPubMedPubMedCentral
9.
go back to reference Ali H, Guy RJ, Wand H, et al. Decline in in-patient treatments of genital warts among young Australians following the national HPV vaccination program. BMC Infect Dis. 2013;13:140.CrossRefPubMedPubMedCentral Ali H, Guy RJ, Wand H, et al. Decline in in-patient treatments of genital warts among young Australians following the national HPV vaccination program. BMC Infect Dis. 2013;13:140.CrossRefPubMedPubMedCentral
10.
go back to reference Scheinfeld N, Lehman DS. An evidence-based review of medical and surgical treatments of genital warts. Dermatol Online J. 2006;12(3):5.PubMed Scheinfeld N, Lehman DS. An evidence-based review of medical and surgical treatments of genital warts. Dermatol Online J. 2006;12(3):5.PubMed
11.
go back to reference Winer RL, Kiviat NB, Hughes JP, Adam DE, Kiviat NB, Koutsky LA. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol. 2003;157:218–26.CrossRefPubMed Winer RL, Kiviat NB, Hughes JP, Adam DE, Kiviat NB, Koutsky LA. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol. 2003;157:218–26.CrossRefPubMed
12.
go back to reference Zur HH. The search for infectious causes of human cancers: where and why. Virology. 2009;392(1):1–10.CrossRef Zur HH. The search for infectious causes of human cancers: where and why. Virology. 2009;392(1):1–10.CrossRef
13.
go back to reference Giuliano AR, Palefsky JM, Goldstone S, et al. Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males. N Engl J Med. 2011;364(5):401–11.CrossRefPubMedPubMedCentral Giuliano AR, Palefsky JM, Goldstone S, et al. Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males. N Engl J Med. 2011;364(5):401–11.CrossRefPubMedPubMedCentral
15.
go back to reference Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19:335–51.CrossRefPubMed Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19:335–51.CrossRefPubMed
16.
go back to reference Baldo V, Cocchio S, Buja A, et al. Hospitalization for diseases attributable to human papillomavirus in the Veneto region (north-East Italy). BMC Infect Dis. 2013;13:462.CrossRefPubMedPubMedCentral Baldo V, Cocchio S, Buja A, et al. Hospitalization for diseases attributable to human papillomavirus in the Veneto region (north-East Italy). BMC Infect Dis. 2013;13:462.CrossRefPubMedPubMedCentral
17.
go back to reference Grulich AE, de Visser RO, Badcock PB, et al. Knowledge about and experience of sexually transmissible infections in a representative sample of adults: the second Australian study of health and relationships. Sex Health. 2014;11(5):481–94.CrossRefPubMed Grulich AE, de Visser RO, Badcock PB, et al. Knowledge about and experience of sexually transmissible infections in a representative sample of adults: the second Australian study of health and relationships. Sex Health. 2014;11(5):481–94.CrossRefPubMed
18.
go back to reference Pirotta M, Stein AN, Conway EL, Harrison C, Britt H, Garland S. Genital warts incidence and healthcare resource utilisation in Australia. Sex Transm Infect. 2010;86(3):181–6.CrossRefPubMed Pirotta M, Stein AN, Conway EL, Harrison C, Britt H, Garland S. Genital warts incidence and healthcare resource utilisation in Australia. Sex Transm Infect. 2010;86(3):181–6.CrossRefPubMed
19.
go back to reference Freedman E, Britt H, Harrison CM, Mindel A. Sexual health problems managed in Australian general practice: a national, cross sectional survey. Sex Transm Infect. 2006;82(1):61–6.CrossRefPubMedPubMedCentral Freedman E, Britt H, Harrison CM, Mindel A. Sexual health problems managed in Australian general practice: a national, cross sectional survey. Sex Transm Infect. 2006;82(1):61–6.CrossRefPubMedPubMedCentral
20.
go back to reference Read TR, Hocking JS, Chen MY, Donovan B, Bradshaw CS, Fairley CK. Hocking et al. the near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme. Sex Transm Infect. 2011;87:544–7.CrossRefPubMed Read TR, Hocking JS, Chen MY, Donovan B, Bradshaw CS, Fairley CK. Hocking et al. the near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme. Sex Transm Infect. 2011;87:544–7.CrossRefPubMed
21.
go back to reference Hartwig S, Baldauf JJ, Dominiak-Feldena G, wt al. Estimation of the epidemiological burden of HPV-related anogenital cancers, precancerous lesions, and genital warts in women and men in Europe: potential additional benefit of a nine-valent second-generation HPV vaccine compared to first-generation HPV vaccines. Papillomavirus Res 2015; 1: 90–100. Hartwig S, Baldauf JJ, Dominiak-Feldena G, wt al. Estimation of the epidemiological burden of HPV-related anogenital cancers, precancerous lesions, and genital warts in women and men in Europe: potential additional benefit of a nine-valent second-generation HPV vaccine compared to first-generation HPV vaccines. Papillomavirus Res 2015; 1: 90–100.
22.
go back to reference Donovan B, Franklin N, Guy R, et al. Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data. Lancet Infect Dis. 2011;11(1):39–44.CrossRefPubMed Donovan B, Franklin N, Guy R, et al. Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data. Lancet Infect Dis. 2011;11(1):39–44.CrossRefPubMed
23.
go back to reference Ali H, Donovan B, Wand H, et al. Genital warts in young Australians five years into national human papillomavirus vaccination program: national surveillance data. BMJ. 2013;346:f2032.CrossRefPubMed Ali H, Donovan B, Wand H, et al. Genital warts in young Australians five years into national human papillomavirus vaccination program: national surveillance data. BMJ. 2013;346:f2032.CrossRefPubMed
24.
go back to reference Palefsky JM, Holly EA, Ralston ML, Jay N. Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men. J Infect Dis. 1998;177:361–7.CrossRefPubMed Palefsky JM, Holly EA, Ralston ML, Jay N. Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men. J Infect Dis. 1998;177:361–7.CrossRefPubMed
25.
go back to reference Zou H, Tabrizi SN, Grulich AE, et al. Early acquisition of anogenital human papillomavirus among teenage men who have sex with men. J Infect Dis. 2014;209(5):642–51.CrossRefPubMed Zou H, Tabrizi SN, Grulich AE, et al. Early acquisition of anogenital human papillomavirus among teenage men who have sex with men. J Infect Dis. 2014;209(5):642–51.CrossRefPubMed
26.
go back to reference Nyitray AG, da Silva RJC, Baggio ML, et al. Age-specific prevalence of and risk factors for anal human papillomavirus (HPV) among men who have sex with women and men who have sex with men: the HPV in men (HIM) study. J Infect Dis. 2011;203(1):49–57.CrossRefPubMedPubMedCentral Nyitray AG, da Silva RJC, Baggio ML, et al. Age-specific prevalence of and risk factors for anal human papillomavirus (HPV) among men who have sex with women and men who have sex with men: the HPV in men (HIM) study. J Infect Dis. 2011;203(1):49–57.CrossRefPubMedPubMedCentral
27.
go back to reference Goldstone S, Palefsky JM, Giuliano AR, et al. Prevalence of and risk factors for human papillomavirus (HPV) infection among HIV-seronegative men who have sex with men. J Infect Dis. 2011;203(1):66–74.CrossRefPubMedPubMedCentral Goldstone S, Palefsky JM, Giuliano AR, et al. Prevalence of and risk factors for human papillomavirus (HPV) infection among HIV-seronegative men who have sex with men. J Infect Dis. 2011;203(1):66–74.CrossRefPubMedPubMedCentral
28.
go back to reference Müller EE, Rebe K, Chirwa TF, Struthers H, McIntyre J, Lewis DA. The prevalence of human papillomavirus infections and associated risk factors in men-who-have-sex-with-men in cape town, South Africa. BMC Infect Dis. 2016;16(1):440.CrossRefPubMedPubMedCentral Müller EE, Rebe K, Chirwa TF, Struthers H, McIntyre J, Lewis DA. The prevalence of human papillomavirus infections and associated risk factors in men-who-have-sex-with-men in cape town, South Africa. BMC Infect Dis. 2016;16(1):440.CrossRefPubMedPubMedCentral
Metadata
Title
Decline in hospitalization for genital warts in the Veneto region after an HPV vaccination program: an observational study
Authors
Silvia Cocchio
Tatjana Baldovin
Chiara Bertoncello
Alessandra Buja
Patrizia Furlan
Mario Saia
Vincenzo Baldo
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2017
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-017-2361-5

Other articles of this Issue 1/2017

BMC Infectious Diseases 1/2017 Go to the issue